SPCG-4: a needed START to PIVOTal data to promote and protect evidence-based prostate cancer care - PubMed (original) (raw)

Editorial

. 2008 Aug 20;100(16):1123-5.

doi: 10.1093/jnci/djn259. Epub 2008 Aug 11.

• PMID: 18695131
• DOI: 10.1093/jnci/djn259

Editorial

SPCG-4: a needed START to PIVOTal data to promote and protect evidence-based prostate cancer care

Timothy J Wilt. J Natl Cancer Inst. 2008.

No abstract available

PubMed Disclaimer

Comment on

• Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.
  Bill-Axelson A, Holmberg L, Filén F, Ruutu M, Garmo H, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spångberg A, Palmgren J, Adami HO, Johansson JE; Scandinavian Prostate Cancer Group Study Number 4. Bill-Axelson A, et al. J Natl Cancer Inst. 2008 Aug 20;100(16):1144-54. doi: 10.1093/jnci/djn255. Epub 2008 Aug 11. J Natl Cancer Inst. 2008. PMID: 18695132 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information